Posts Tagged ‘Amicus Therapeutics’

John F. Crowley

John Crowley is the chairman and CEO of Amicus Therapeutics, Inc. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children, Megan and Patrick, with Pompe disease – an often-fatal neuromuscular disorder. In his drive to find a cure for his children, he left his position at Bristol-Myers Squibb and becameRead more..